|
14 Companies |
|
10 Products |
|
10 Products |
|
17 Mechanisms of Action |
|
1 Trial |
|
129 News |
|
| 123» |
- | Trial completion, Trial completion date, Trial primary completion date: New Treatment for Patients With Temporal Hollowing After Lateral Wall Decompression (clinicaltrials.gov) - Feb 22, 2019
P=N/A, N=29, Completed, Sponsor: Haukeland University Hospital
Enrolling by invitation --> Completed | Trial completion date: Jan 2021 --> May 2018 | Trial primary completion date: Dec 2018 --> Jan 2018
- || Enrollment change: A Trial Comparing Wound Drainage and Post-operative Complications With and Without the Use of EVICEL™ Fibrin Sealant in Thyroidectomy (clinicaltrials.gov) - Feb 5, 2019
P=N/A, N=55, Completed, Sponsor: Medical University of South Carolina
Enrolling by invitation --> Completed | Trial completion date: Jan 2021 --> May 2018 | Trial primary completion date: Dec 2018 --> Jan 2018 N=120 --> 55
- | Trial completion, Enrollment change: Remission Induction and Sustenance in Graves' Disease 2 (clinicaltrials.gov) - Jan 10, 2019
P=N/A, N=139, Completed, Sponsor: Aalborg Universitetshospital
N=120 --> 55 Active, not recruiting --> Completed | N=250 --> 139
- | Trial completion: AT-thyro: Clinical Application of Pulse Rate-monitoring Activity Trackers in Thyrotoxicosis (clinicaltrials.gov) - Apr 18, 2018
P=N/A, N=40, Completed, Sponsor: Seoul National University Bundang Hospital
Active, not recruiting --> Completed | N=250 --> 139 Recruiting --> Completed
- | Lumigan (bimatoprost) / Senju, AbbVie
Trial completion, Enrollment change, Trial primary completion date: Treatment of Soft Tissue Expansion in Inactive Thyroid Eye Disease Patients Using Drops of Prostaglandin Analogues (clinicaltrials.gov) - Feb 19, 2018
P3, N=10, Completed, Sponsor: Rabin Medical Center
Recruiting --> Completed Recruiting --> Completed | N=20 --> 10 | Trial primary completion date: Dec 2015 --> May 2017
- | Trial completion, Trial primary completion date: Study of the Efficacy of Local Analgesia as an Adjunct to General Anesthesia in Thyroidectomy and Parathyroidectomy (clinicaltrials.gov) - Feb 7, 2018
P=N/A, N=36, Completed, Sponsor: University of Chicago
Recruiting --> Completed | N=20 --> 10 | Trial primary completion date: Dec 2015 --> May 2017 Enrolling by invitation --> Completed | Trial primary completion date: Jun 2017 --> Feb 2017
- | Lumigan (bimatoprost) / Senju, AbbVie, Zioptan (tafluprost) / Santen, Merck (MSD)
Enrollment change, Trial initiation date, Trial primary completion date: The Secondary Beneficial Effects of Prostaglandin Analog Treatment in Thyroid Eye Disease Patients. (clinicaltrials.gov) - Jan 16, 2018
P4, N=0, Withdrawn, Sponsor: Stanford University
Enrolling by invitation --> Completed | Trial primary completion date: Jun 2017 --> Feb 2017 N=30 --> 0 | Initiation date: Aug 2013 --> Jun 2014 | Trial primary completion date: Aug 2015 --> Dec 2016
- | Tepezza (teprotumumab-trbw) / Roche, Amgen
Trial completion: Teprotumumab (RV 001) Treatment in Patients With Active Thyroid Eye Disease (clinicaltrials.gov) - Aug 30, 2017
P2, N=88, Completed, Sponsor: Horizon Pharma USA, Inc.
N=30 --> 0 | Initiation date: Aug 2013 --> Jun 2014 | Trial primary completion date: Aug 2015 --> Dec 2016 Active, not recruiting --> Completed
- | Trial completion, Enrollment change: GOCol: Graves' Orbitopathy and Hypercholesterolemia (clinicaltrials.gov) - Aug 10, 2017
P=N/A, N=250, Completed, Sponsor: University of Pisa
Active, not recruiting --> Completed Recruiting --> Completed | N=200 --> 250
- | Trial primary completion date: Study of the Efficacy of Local Analgesia as an Adjunct to General Anesthesia in Thyroidectomy and Parathyroidectomy (clinicaltrials.gov) - Jun 29, 2017
P=N/A, N=40, Enrolling by invitation, Sponsor: University of Chicago
Recruiting --> Completed | N=200 --> 250 Trial primary completion date: Jan 2018 --> Jun 2017
- | azithromycin / Generic mfg.
Enrollment change, Trial withdrawal, Trial primary completion date, Immunomodulating: Use of Azithromycin as Immunomodulatory Therapy in Grave&Apos;s Orbitopathy (clinicaltrials.gov) - Apr 27, 2017
P1/2, N=0, Withdrawn, Sponsor: Rabin Medical Center
Trial primary completion date: Jan 2018 --> Jun 2017 N=14 --> 0 | Enrolling by invitation --> Withdrawn | Trial primary completion date: Jul 2012 --> Nov 2014
- | Trial completion: The Oncopanel Pilot (TOP) Study (clinicaltrials.gov) - Apr 14, 2017
P=N/A, N=432, Completed, Sponsor: British Columbia Cancer Agency
N=14 --> 0 | Enrolling by invitation --> Withdrawn | Trial primary completion date: Jul 2012 --> Nov 2014 Active, not recruiting --> Completed
- | Trial completion: Post-Radioiodine Graves' Management: The PRAGMA-Study (clinicaltrials.gov) - Mar 30, 2017
P=N/A, N=803, Completed, Sponsor: Newcastle-upon-Tyne Hospitals NHS Trust
Active, not recruiting --> Completed Recruiting --> Completed
- | New trial: Tracheal Anatomy After Thyroidectomy (clinicaltrials.gov) - Mar 7, 2017
P=N/A, N=72, Completed, Sponsor: University of Southern Denmark
- | Enrollment open, Enrollment change, Trial primary completion date: GOCol: Graves' Orbitopathy and Hypercholesterolemia (clinicaltrials.gov) - Feb 20, 2017
P=N/A, N=200, Recruiting, Sponsor: University of Pisa
Recruiting --> Completed Completed --> Recruiting | N=100 --> 200 | Trial primary completion date: Jan 2017 --> May 2017
- | Trial primary completion date: GOCol: Graves' Orbitopathy and Hypercholesterolemia (clinicaltrials.gov) - Feb 16, 2017
P=N/A, N=100, Completed, Sponsor: University of Pisa
Completed --> Recruiting | N=100 --> 200 | Trial primary completion date: Jan 2017 --> May 2017 Trial primary completion date: Jun 2016 --> Jan 2017
- Trial primary completion date: The Oncopanel Pilot (TOP) Study (clinicaltrials.gov) - Feb 3, 2017
P=N/A, N=432, Active, not recruiting, Sponsor: British Columbia Cancer Agency
Trial primary completion date: Jun 2016 --> Jan 2017 Trial primary completion date: Nov 2016 --> Mar 2017
- New trial: AT-thyro: Clinical Application of Pulse Rate-monitoring Activity Trackers in Thyrotoxicosis (clinicaltrials.gov) - Jan 3, 2017
P=N/A, N=40, Recruiting, Sponsor: Seoul National University Bundang Hospital
- ||| Tepezza (teprotumumab-trbw) / Roche, Amgen
Trial initiation date: Teprotumumab (RV 001) Treatment in Patients With Active Thyroid Eye Disease (clinicaltrials.gov) - Nov 25, 2016
P2, N=84, Active, not recruiting, Sponsor: River Vision Development Corporation
Trial primary completion date: Nov 2016 --> Mar 2017 Initiation date: Apr 2013 --> Jul 2013
- Trial completion, Trial initiation date, Trial primary completion date: HIFURGD: A Evaluation of High Intensity Focused Ultrasound (HIFU) in the Treatment of Relapsed Graves' Disease (clinicaltrials.gov) - Nov 10, 2016
P=N/A, N=22, Completed, Sponsor: The University of Hong Kong
Initiation date: Apr 2013 --> Jul 2013 Recruiting --> Completed | Initiation date: Feb 2016 --> Oct 2015 | Trial primary completion date: Jun 2017 --> Apr 2016
- Enrollment closed, HEOR: SOLOIST: Changes in Quality of Life Following Surgical Treatment of Benign Non-toxic Goiter (clinicaltrials.gov) - Nov 8, 2016
P=N/A, N=104, Active, not recruiting, Sponsor: University of Southern Denmark
Recruiting --> Completed | Initiation date: Feb 2016 --> Oct 2015 | Trial primary completion date: Jun 2017 --> Apr 2016 Recruiting --> Active, not recruiting
- Trial completion, Trial primary completion date: MyEndo-Thyroid: Thyroid Disorders in Malaysia: A Nationwide Multicentre Study (clinicaltrials.gov) - Oct 18, 2016
P=N/A, N=2498, Completed, Sponsor: International Islamic University Malaysia
Recruiting --> Active, not recruiting Enrolling by invitation --> Completed | Trial primary completion date: May 2016 --> Sep 2016
- Trial completion: GOCol: Graves' Orbitopathy and Hypercholesterolemia (clinicaltrials.gov) - Oct 18, 2016
P=N/A, N=100, Completed, Sponsor: University of Pisa
Enrolling by invitation --> Completed | Trial primary completion date: May 2016 --> Sep 2016 Recruiting --> Completed
- Trial completion: Galectin 3 Dosage in Diagnosis of Nodular and Multinodular Goiter (clinicaltrials.gov) - Oct 10, 2016
P=N/A, N=193, Completed, Sponsor: University Hospital, Rouen
Recruiting --> Completed Active, not recruiting --> Completed
- Trial primary completion date: Study of the Efficacy of Local Analgesia as an Adjunct to General Anesthesia in Thyroidectomy and Parathyroidectomy (clinicaltrials.gov) - Aug 31, 2016
P=N/A, N=40, Enrolling by invitation, Sponsor: University of Chicago
Active, not recruiting --> Completed Trial primary completion date: Jan 2016 --> Jan 2018
- Trial completion, Enrollment change: Evaluation of the Effects of Teleconsultations on a Endocrinology Referral List (clinicaltrials.gov) - Aug 10, 2016
P=N/A, N=3470, Completed, Sponsor: Hospital de Clinicas de Porto Alegre
Trial primary completion date: Jan 2016 --> Jan 2018 Recruiting --> Completed | N=2016 --> 3470
- Trial primary completion date: The Oncopanel Pilot (TOP) Study (clinicaltrials.gov) - Jul 21, 2016
P=N/A, N=432, Active, not recruiting, Sponsor: British Columbia Cancer Agency
Recruiting --> Completed | N=2016 --> 3470 Trial primary completion date: Jun 2016 --> Sep 2016
- New trial: GPCBasedow: Prevalence of Circulating Parvovirus Genome in Recently Diagnosed Graves' Disease: a Case-control Study (clinicaltrials.gov) - Jun 15, 2016
P=N/A, N=52, Completed, Sponsor: Centre Hospitalier Universitaire, Amiens
- Trial completion, Enrollment change, Trial primary completion date: Radioactive Iodide Therapy for Pediatric Graves' Disease (clinicaltrials.gov) - Jun 13, 2016
P2, N=22, Completed, Sponsor: University of Florida
Trial primary completion date: Jun 2016 --> Sep 2016 Recruiting --> Completed | N=300 --> 22 | Trial primary completion date: Aug 2018 --> Jun 2016
- Enrollment change: GOCol: Graves' Orbitopathy and Hypercholesterolemia (clinicaltrials.gov) - Jun 1, 2016
P=N/A, N=100, Recruiting, Sponsor: University of Pisa
Recruiting --> Completed | N=300 --> 22 | Trial primary completion date: Aug 2018 --> Jun 2016 N=66 --> 100
- New trial: Optic Disc, Macula, and Retinal Nerve Fiber Layer Measurements Obtained by OCT in Thyroid Associated Ophthalmopathy (clinicaltrials.gov) - May 10, 2016
P=N/A, N=102, Completed, Sponsor: Neon Hospital
- Lumigan (bimatoprost) / Senju, AbbVie
Trial completion, Trial primary completion date: Prostaglandin F2-alpha Eye Drops in Thyroid Eye Disease (Bima Study) (clinicaltrials.gov) - May 6, 2016
P4, N=31, Completed, Sponsor: Cardiff University
N=66 --> 100 Active, not recruiting --> Completed | Trial primary completion date: Dec 2015 --> Mar 2016
- Enrollment closed, Enrollment change: The Oncopanel Pilot (TOP) Study (clinicaltrials.gov) - Apr 26, 2016
P=N/A, N=432, Active, not recruiting, Sponsor: British Columbia Cancer Agency
Active, not recruiting --> Completed | Trial primary completion date: Dec 2015 --> Mar 2016 Recruiting --> Active, not recruiting | N=1000 --> 432
- methimazole / Generic mfg.
New trial: Treatment of Graves' Hyperthyroidism With Selenium Plus Methimazole (clinicaltrials.gov) - Apr 6, 2016
P=N/A, N=30, Completed, Sponsor: University of Pisa
- New trial: GOCol: Graves' Orbitopathy and Hypercholesterolemia (clinicaltrials.gov) - Mar 29, 2016
P=N/A, N=66, Recruiting, Sponsor: University of Pisa
- New trial: Evaluation of the Effects of Teleconsultations on a Endocrinology Referral List (clinicaltrials.gov) - Mar 18, 2016
P=N/A, N=2016, Recruiting, Sponsor: Hospital de Clinicas de Porto Alegre
- New trial: New Treatment for Patients With Temporal Hollowing After Lateral Wall Decompression (clinicaltrials.gov) - Feb 29, 2016
P=N/A, N=40, Enrolling by invitation, Sponsor: Haukeland University Hospital
- MIKA Diclofenac Spray Gel (diclofenac spraygel) / Nogra Pharma
Trial completion, Trial primary completion date: Adjuvant Treatment of Graves (clinicaltrials.gov) - Feb 24, 2016
P4, N=65, Completed, Sponsor: Mikael Lantz
Recruiting --> Active, not recruiting | N=1000 --> 432 Active, not recruiting --> Completed | Trial primary completion date: May 2015 --> Feb 2016
- New trial: HIFURGD: A Evaluation of High Intensity Focused Ultrasound (HIFU) in the Treatment of Relapsed Graves' Disease (clinicaltrials.gov) - Feb 18, 2016
P=N/A, N=22, Recruiting, Sponsor: The University of Hong Kong
- Actemra IV (tocilizumab) / Roche, JW Pharma
Trial completion, Trial primary completion date: Tocilizumab Treatment in Graves (clinicaltrials.gov) - Jan 20, 2016
P3, N=32, Completed, Sponsor: Hospital Clinico Universitario de Santiago
Active, not recruiting --> Completed | Trial primary completion date: May 2015 --> Feb 2016 Active, not recruiting --> Completed | Trial primary completion date: Jun 2015 --> Oct 2015
- Trial primary completion date: The Oncopanel Pilot (TOP) Study (clinicaltrials.gov) - Jan 18, 2016
P=N/A, N=1000, Recruiting, Sponsor: British Columbia Cancer Agency
Active, not recruiting --> Completed | Trial primary completion date: Jun 2015 --> Oct 2015 Trial primary completion date: Sep 2016 --> Jun 2016
- New trial, HEOR: SOLOIST: Changes in Quality of Life Following Surgical Treatment of Benign Non-toxic Goiter (clinicaltrials.gov) - Jan 11, 2016
P=N/A, N=104, Recruiting, Sponsor: University of Southern Denmark
- Phase classification, Trial primary completion date: Remission Induction and Sustenance in Graves' Disease 2 (clinicaltrials.gov) - Dec 31, 2015
P=N/A, N=250, Active, not recruiting, Sponsor: Aalborg Universitetshospital
Trial primary completion date: Sep 2016 --> Jun 2016 Phase classification: P4 --> P=N/A | Trial primary completion date: Oct 2015 --> Oct 2017
- Enrollment closed, Enrollment change: Galectin 3 Dosage in Diagnosis of Nodular and Multinodular Goiter (clinicaltrials.gov) - Dec 9, 2015
P=N/A, N=193, Active, not recruiting, Sponsor: University Hospital, Rouen
Phase classification: P4 --> P=N/A | Trial primary completion date: Oct 2015 --> Oct 2017 Recruiting --> Active, not recruiting | N=500 --> 193
- Trial primary completion date: Post-Radioiodine Graves' Management: The PRAGMA-Study (clinicaltrials.gov) - Oct 22, 2015
P=N/A, N=750, Recruiting, Sponsor: Newcastle-upon-Tyne Hospitals NHS Trust
Recruiting --> Active, not recruiting | N=500 --> 193 Trial primary completion date: Mar 2014 --> Feb 2015
- Trial primary completion date: MyEndo-Thyroid: Thyroid Disorders in Malaysia: A Nationwide Multicentre Study (clinicaltrials.gov) - Sep 24, 2015
P=N/A, N=2500, Enrolling by invitation, Sponsor: International Islamic University Malaysia
Trial primary completion date: Mar 2014 --> Feb 2015 Trial primary completion date: May 2015 --> May 2016
- ||| Tepezza (teprotumumab-trbw) / Roche, Amgen
Enrollment closed, Trial primary completion date: Teprotumumab (RV 001) Treatment in Patients With Active Thyroid Eye Disease (clinicaltrials.gov) - Sep 22, 2015
P2, N=84, Active, not recruiting, Sponsor: River Vision Development Corporation
Trial primary completion date: May 2015 --> May 2016 Recruiting --> Active, not recruiting | Trial primary completion date: Oct 2015 --> Mar 2016
- Lumigan (bimatoprost) / Senju, AbbVie
Enrollment open, Trial initiation date: Treatment of Soft Tissue Expansion in Inactive Thyroid Eye Disease Patients Using Drops of Prostaglandin Analogues (clinicaltrials.gov) - Jun 16, 2015
P3, N=20, Recruiting, Sponsor: Rabin Medical Center
Recruiting --> Active, not recruiting | Trial primary completion date: Oct 2015 --> Mar 2016 Not yet recruiting --> Recruiting | Initiation date: Jun 2014 --> Nov 2014
- Trial primary completion date: Study of the Efficacy of Local Analgesia as an Adjunct to General Anesthesia in Thyroidectomy and Parathyroidectomy (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=40, Enrolling by invitation, Sponsor: University of Chicago
Not yet recruiting --> Recruiting | Initiation date: Jun 2014 --> Nov 2014 Trial primary completion date: Jan 2015 --> Jan 2016
- Botox (onabotulinumtoxin A) / GSK, AbbVie, Healis Therap
Enrollment change, Trial withdrawal: Use of Botox in the Management of Thyroid Related Upper Eyelid Retraction (clinicaltrials.gov) - Jun 3, 2015
P4, N=0, Withdrawn, Sponsor: University of Toronto
Trial primary completion date: Jan 2015 --> Jan 2016 N=20 --> 0 | Not yet recruiting --> Withdrawn